remdesivir
-
Coronavirus: WHO advises against use of remdesivir, says it has no important effect on mortality
Scroll Staff
-
Coronavirus: Gilead’s remdesivir first to receive US approval for treatment
Scroll Staff
-
Covid-19: Remdesivir does not reduce deaths or hospital stay, shows WHO study
Scroll Staff
-
Coronavirus: Zydus Cadila launches its remdesivir version in India, priced at Rs 2,800 per vial
Scroll Staff
-
In India, black markets for tocilizumab spring up as demand for the Covid-19 drug surges
Anoo Bhuyan, IndiaSpend.com
-
Coronavirus: Health ministry revises dosage of anti-viral drug remdesivir for Covid-19 patients
Scroll Staff
-
Coronavirus: Maharashtra, Delhi in list of five states to get first set of remdesivir drug
Scroll Staff
-
Coronavirus: Pharma firm Hetero gets drug controller’s nod to produce, market remdesivir
Scroll Staff
-
Covid-19: Two Indian firms sign deal with Gilead to sell, manufacture antiviral drug remdesivir
Scroll Staff
-
Coronavirus: US allows emergency use of antiviral drug remdesivir to treat patients
Scroll Staff